60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Mar 27, 2025 · 10-K · 86 days after period end · 0001013762-25-003343
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|
| Revenue | $241.64K | $125.68K | — |
| Net Income | -$2.05M | -$2.01M | -$1.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d after period end
